AstraZeneca’s tremelimumab does not perform well in NSCLC trial
Does AstraZeneca pay its CEO too much?
The latest on Brexit and the pharma industry
Boston Scientific plans $200M restructuring
*please scroll down for all the latest news*
*scroll through previous pages at the bottom to get older news*
Today's most popular searches:
For banking news and anonymous forums, be sure to check out cafebanking.com
